• / Free eNewsletters & Magazine
  • / My Account
Home>Drug Companies

Drug Companies

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. UPDATE: U.S. Firms Urge China to Improve Conditions

    UPDATE: U.S. Firms Urge China to Improve Conditions

  2. U.S. Firms Want China to Improve Business Conditions

    U.S. Firms Want China to Improve Business Conditions

  3. Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation

    Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation

  4. Lifshitz & Miller Law Firm Announces Investigation of Acadia Pharmaceuticals Inc., Akorn, Inc., Dover Saddlery, Inc., Excel Trust, Inc., Informatica Corporation, Inogen, Inc. and Zep, Inc.

    Lifshitz & Miller Law Firm Announces Investigation of Acadia Pharmaceuticals Inc., Akorn, Inc., Dover Saddlery, Inc., Excel Trust, Inc., Informatica Corporation, Inogen, Inc. and Zep, Inc.

  5. SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Acadia Pharmaceuticals Inc. and a Lead Plaintiff Deadline of May 12, 2015

    SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Acadia Pharmaceuticals Inc. and a Lead Plaintiff Deadline of May 12, 2015

  6. DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 for Treatment of Non-Small Cell Lung Cancer at the American Association of Cancer Research Annual Meeting

    DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 for Treatment of Non-Small Cell Lung Cancer at the American Association of Cancer Research Annual Meeting

  7. Systech International Names Jim Lee VP, Product Management

    Systech International Names Jim Lee VP, Product Management

  8. Research and Markets: MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")

    Research and Markets: MedIntelliBase Lower Limb Critical Limb Ischemia Therapeutics MarketTracksTM ("CLI-LL MarketTracks")

  9. BioMed Realty Earns Upgraded Investment Grade Corporate Credit Rating From Moody's Investors Service

    BioMed Realty Earns Upgraded Investment Grade Corporate Credit Rating From Moody's Investors Service

  10. Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO

    Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.